The Patent Finder

Medicinal Bioconvergence Research Center

Also on record
Records under this name other than the patents Medicinal Bioconvergence Research Center holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.

Back to Medicinal Bioconvergence Research Center

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,573,907Novel 2, 4-Pyrimidine Derivatives and Use Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,677,806Composition for Diagnosing Follicular Thyroid Carcinoma Using Expression Level of Aminoacyl-Trna Synthetase-Related Protein and Method for Detecting Diagnostic Marker
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,207,389Composition for treatment or prevention of infectious inflammatory diseases, or composition for immune enhancement, comprising tryptophanyl-tRNA synthetase as an active ingredient
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,378,572Therapeutic agent for immune cell migration-caused disease and method for screening same
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,965,038Pharmaceutical composition comprising antibody binding specifically to lysyl-tRNA synthetase N-terminus as effective ingredient for preventing or treating immune cell migration-related disease
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,685,791Antibody binding specifically to N-terminal region of lysyl-tRNA synthetase exposed on cell membrane
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,130,611Use of Benzo-Heterocycle Derivatives for Preventing and Treating Cancer or for Inhibiting Cancer Metastasis
Grace period ended
 · Low confidence
Grace period endedLow confidence
US 11,442,057Method for Screening Anticancer Agent Inhibiting Binding of AIMP2-DX2 and HSP70
Lapsed on the fee record
Ended Sep 13, 2026 · High confidence
Lapsed on the fee recordEnded Sep 13, 2026High confidence
US 11,360,093Colorectal cancer diagnostic composition, and method for detecting diagnostic marker
Lapsed on the fee record
Ended Jun 14, 2026 · USPTO record
Lapsed on the fee recordEnded Jun 14, 2026USPTO record
US 7,459,529AIMP2-DX2 and Its Uses
Term ended
Term ended Nov 1, 2025 · High confidence
Term endedTerm ended Nov 1, 2025High confidence
10 of 19 patents shown.
Pro members see all 19.
Pro members: see all 19 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited